BRD2492

CAS No. 1821669-43-5

BRD2492( BRD 2492 )

Catalog No. M12810 CAS No. 1821669-43-5

BRD2492 is a highly potent, selective HDAC1/2 inhibitor (IC50=2/19 nM, respectively).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 101 In Stock
10MG 150 In Stock
25MG 255 In Stock
50MG 365 In Stock
100MG 544 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    BRD2492
  • Note
    Research use only, not for human use.
  • Brief Description
    BRD2492 is a highly potent, selective HDAC1/2 inhibitor (IC50=2/19 nM, respectively).
  • Description
    BRD2492 is a highly potent, selective HDAC1/2 inhibitor (IC50=2/19 nM, respectively) that displays excellent selectivity versus HDAC3 (IC50=2.08 uM, ≥110-fold selectivity) and all other HDAC isoforms, increases caspase-3 activation.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    BRD 2492
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    HDAC
  • Recptor
    HDAC
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1821669-43-5
  • Formula Weight
    346.39
  • Molecular Formula
    C20H18N4O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 31.25 mg/mL (90.22 mM)
  • SMILES
    O=C(NC1=CC(C2=CC=NC=C2)=CC=C1N)C3=CC=C(NC(C)=O)C=C3
  • Chemical Name
    4-Acetylamino-N-(2-amino-5-pyridin-4-yl-phenyl)-benzamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Wagner FF, et al. ACS Chem Biol. 2016 Feb 19;11(2):363-74.
molnova catalog
related products
  • SR-18292

    SR-18292 is a PPAR gamma coactivator-1α (PGC-1α) inhibitor, which increases PGC-1α acetylation, suppresses gluconeogenic gene expression and reduces glucose production in hepatocytes.

  • MPT0G211

    MPT0G211 is a novel potent, selective HDAC6 inhibitor with IC50 of 0.291 nM.

  • Tefinostat

    Tefinostat (CHR-2845) is a potent monocyte/macrophage-targeted histone deacetylase (HDAC) inhibitor that is cleaved to the active acid CHR-2847 by intracellular esterase human carboxylesterase-1 (hCE-1).